US Patent 10730954 MSLN targeting trispecific proteins and methods of use
Patent 10730954 was granted and assigned to Harpoon Therapeutics on August, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10730954 MSLN targeting trispecific proteins and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
